Stephen Alister Locarnini

This inventor holds 14 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Melbourne Health, Austin Health, Southern Health. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Alister Locarnini. Retrieved from https://idiyas.com/inventor/stephen-alister-locarnini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 2)

% Patents Active = 28.6

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 68(Granted Patents)

Location History:

St Kilda East, AU (2005)
Victoria, AU (2008 - 2011)
St. Kilda, AU (2008 - 2012)
East St. Kilda, AU (2003 - 2013)

Company Filing History:

Austin and Repatriation Medical Centre

patents

6. 2 out of 11

Central Sydney Area Health Service

patents

7. 2 out of 5

St. Vincents Hospital (Melbourne) Limited

The Penn State Research Foundation

patents

11. 1 out of 1

Western Health Care Network

patent

where one patent can have more than one assignee

Years Active: 2003-2013

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8592143 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof (2013-11-26),

2. 8211633 - Viral variants with altered susceptibility to nucleoside analogs and uses thereof (2012-07-03),

3. 8008000 - Viral variants detection and application (2011-08-30),

4. 7989162 - Viral variants with altered susceptibility to nucleoside analogs and uses thereof (2011-08-02),

5. 7931907 - Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same (2011-04-26),

6. 7875423 - HBV variants detection and application (2011-01-25),

7. 7846663 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof (2010-12-07),

8. 7745130 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof (2010-06-29),

9. 7431933 - Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same (2008-10-07),

10. 7405039 - Viral variants with altered susceptibility to nucleoside analogs and uses thereof (2008-07-29),

11. 7384747 - Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof (2008-06-10),

12. RE40233 - Viral variants and methods for detecting same (2008-04-07),

13. 6969583 - Method for detecting variant HBV (2005-11-29),

14. 6555311 - Viral variants and methods for detecting same (2003-04-29),

Title: The Innovative Journey of Stephen Alister Locarnini

Introduction: Stephen Alister Locarnini, a distinguished inventor hailing from East St. Kilda, AU, has made significant contributions to the field of technology and innovation.

Latest Patents: Stephen Alister Locarnini's latest patents focus on advancements in medical technology, particularly in the areas of diagnostic tools and treatment methods for infectious diseases.

Career Highlights: With a career spanning over two decades, Locarnini has been at the forefront of groundbreaking research in the medical and technological sectors. His work has led to the development of cutting-edge solutions that have revolutionized the way we approach healthcare.

Collaborations: Throughout his career, Stephen Alister Locarnini has collaborated with leading researchers, scientists, and medical professionals from around the world. These collaborations have been instrumental in driving innovation and pushing the boundaries of what is possible in the field of medical technology.

Conclusion: Stephen Alister Locarnini's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a visionary inventor. His work continues to inspire and shape the future of technology and healthcare.

Profile summary based on public USPTO records.